rs2295080
| Orientation | plus |
| Stabilized | plus |
| Make rs2295080(G;G) |
| Make rs2295080(G;T) |
| Make rs2295080(T;T) |
| Reference | GRCh38 38.1/141 |
| Chromosome | 1 |
| Position | 11262571 |
| Gene | MTOR |
| is a | snp |
| is | mentioned by |
| dbSNP | rs2295080 |
| dbSNP (classic) | rs2295080 |
| ClinGen | rs2295080 |
| ebi | rs2295080 |
| HLI | rs2295080 |
| Exac | rs2295080 |
| Gnomad | rs2295080 |
| Varsome | rs2295080 |
| LitVar | rs2295080 |
| Map | rs2295080 |
| PheGenI | rs2295080 |
| Biobank | rs2295080 |
| 1000 genomes | rs2295080 |
| hgdp | rs2295080 |
| ensembl | rs2295080 |
| geneview | rs2295080 |
| scholar | rs2295080 |
| rs2295080 | |
| pharmgkb | rs2295080 |
| gwascentral | rs2295080 |
| openSNP | rs2295080 |
| 23andMe | rs2295080 |
| SNPshot | rs2295080 |
| SNPdbe | rs2295080 |
| MSV3d | rs2295080 |
| GWAS Ctlg | rs2295080 |
| GMAF | 0.4141 |
| Max Magnitude | 0 |
| ? | (G;G) (G;T) (T;T) | 28 |
|---|---|---|
|
| ||
[PMID 23209702
] A Functional Variant in the MTOR Promoter Modulates Its Expression and Is Associated with Renal Cell Cancer Risk
[PMID 22815832] Genetic variations in a PTEN/AKT/mTOR axis and prostate cancer risk in a Chinese population
[PMID 19164214] Genetic variations in the PI3K/PTEN/AKT/mTOR pathway are associated with clinical outcomes in esophageal cancer patients treated with chemoradiotherapy.
[PMID 21973240] Association of genetic variations in mTOR with risk of childhood acute lymphoblastic leukemia in a Chinese population.
[PMID 26108313] [Association of mammalian target of rapamycin gene polymorphisms with the risk of pediatric epilepsy]
[PMID 29259266] Associations of genetic polymorphisms in pTEN/AKT/mTOR signaling pathway genes with cancer risk: A meta-analysis in Asian population.
[PMID 29383014] Association between single nucleotide polymorphisms in the PI3K/AKT/mTOR pathway and bladder cancer risk in a sample of Iranian population.
[PMID 31303410] SNPs Within the MTOR Gene Are Associated With an Increased Risk of Developing De Novo Diabetes Mellitus Following the Administration of Everolimus in Liver Transplant Recipients.
[PMID 31467112] Breast cancer risk-associated SNPs in the mTOR promoter form de novo KLF5 and ZEB1 binding sites that influence the cellular response to paclitaxel.
[PMID 33083391] Impact of mTOR gene polymorphisms and gene-tea interaction on susceptibility to tuberculosis.
